Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.
about
Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Long-term efficacy and safety ...... en-label study of 15 patients.
@en
Long-term efficacy and safety ...... en-label study of 15 patients.
@nl
type
label
Long-term efficacy and safety ...... en-label study of 15 patients.
@en
Long-term efficacy and safety ...... en-label study of 15 patients.
@nl
prefLabel
Long-term efficacy and safety ...... en-label study of 15 patients.
@en
Long-term efficacy and safety ...... en-label study of 15 patients.
@nl
P2093
P2860
P50
P1433
P1476
Long-term efficacy and safety ...... en-label study of 15 patients.
@en
P2093
Christelle Sordet
Cédric Lukas
Emmanuel Chatelus
François Lefebvre
Gilles Blaison
Jacques-Eric Gottenberg
Jean Durckel
Jean Sibilia
Jean-François Kleinmann
Joelle Goetz
P2860
P304
P356
10.1136/RMDOPEN-2017-000555
P577
2017-12-29T00:00:00Z